{
    "Trade/Device Name(s)": [
        "INTROLTM CF Panel I Control"
    ],
    "Submitter Information": "Maine Molecular Quality Controls, Inc.",
    "510(k) Number": "K083171",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060070"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NZB"
    ],
    "Summary Letter Date": "December 16, 2008",
    "Summary Letter Received Date": "October 27, 2008",
    "Submission Date": "October 19, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.5910"
    ],
    "Regulation Name(s)": [
        "DNA quality control material for genetic testing"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene mutations",
        "CFTR variants",
        "I506V",
        "I507V",
        "F508C",
        "5/7/9T variants"
    ],
    "Specimen Type(s)": [
        "Whole Blood (simulated)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Extraction",
        "Amplification",
        "Detection"
    ],
    "Methodologies": [
        "Nucleic acid control",
        "Quality control material"
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for INTROLTM CF Panel I Control as a DNA quality control material for CFTR mutation genetic testing assays",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as a quality control to monitor analytical performance of extraction, amplification, and detection steps of diagnostic assays used for detecting CFTR gene mutations and variants.",
    "fda_folder": "Microbiology"
}